# PAZOPANIB HYDROCHLORIDE
> **ANDA218231** · Abbreviated New Drug Application (Generic) · Sponsor: NOVUGEN · Approved 2024-04-23
## Drug
- **FDA Application Number:** ANDA218231
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PAZOPANIB HYDROCHLORIDE
- **Generic name:** PAZOPANIB HYDROCHLORIDE
- **Active ingredients:** PAZOPANIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVUGEN
- **Manufacturer:** Novugen Pharma (USA) LLC.
- **First approval:** 2024-04-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218231)
---
*AI Analytics · CC0 1.0*